158 related articles for article (PubMed ID: 8517786)
1. Accumulation of 1-methyl-tetrahydro-beta-carboline-3-carboxylic acid in blood and organs of rat. A possible causative substance of eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan.
Ogawa Y; Adachi J; Tatsuno Y
Arch Toxicol; 1993; 67(4):290-3. PubMed ID: 8517786
[TBL] [Abstract][Full Text] [Related]
2. Endogenous formation of 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3- carboxylic acid in man as the possible causative substance of eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan.
Adachi J; Yamamoto K; Ogawa Y; Ueno Y; Mizoi Y; Tatsuno Y
Arch Toxicol; 1991; 65(6):505-9. PubMed ID: 1929872
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and distribution in the rat of peak E substance, a constituent in L-tryptophan product implicated in eosinophilia-myalgia syndrome.
Adachi J; Naito T; Ueno Y; Ogawa Y; Ninomiya I; Tatsuno Y
Arch Toxicol; 1993; 67(4):284-9. PubMed ID: 8517785
[TBL] [Abstract][Full Text] [Related]
4. Acetaldehyde-induced formation of 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid in rats.
Adachi J; Ueno Y; Ogawa Y; Hishida S; Yamamoto K; Ouchi H; Tatsuno Y
Biochem Pharmacol; 1993 Feb; 45(4):935-41. PubMed ID: 8452569
[TBL] [Abstract][Full Text] [Related]
5. Tetrahydro-beta-carboline-3-carboxylic acids and contaminants of L-tryptophan.
Adachi J; Asano M; Ueno Y
J Chromatogr A; 2000 Jun; 881(1-2):501-15. PubMed ID: 10905731
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of 3-(phenylamino)alanine, a constituent in L-tryptophan products implicated in eosinophilia-myalgia syndrome, in blood and organs of the Lewis rats.
Adachi J; Gomez M; Smith CC; Sternberg EM
Arch Toxicol; 1995; 69(4):266-70. PubMed ID: 7755488
[TBL] [Abstract][Full Text] [Related]
7. Identification of tetrahydro-beta-carboline-3-carboxylic acid in foodstuffs, human urine and human milk.
Adachi J; Mizoi Y; Naito T; Ogawa Y; Uetani Y; Ninomiya I
J Nutr; 1991 May; 121(5):646-52. PubMed ID: 2019874
[TBL] [Abstract][Full Text] [Related]
8. 1,1'-Ethylidenebis[L-tryptophan], an impurity in L-tryptophan associated with eosinophilia-myalgia syndrome, stimulates type I collagen gene expression in human fibroblasts in vitro.
Zangrilli JG; Mayeno AN; Vining V; Varga J
Biochem Mol Biol Int; 1995 Nov; 37(5):925-33. PubMed ID: 8624499
[TBL] [Abstract][Full Text] [Related]
9. Age-related accumulation of 1-methyl-1,2,3,4-tetrahydro-beta-carboline-3- carboxylic acid in human lens.
Manabe S; Yuan J; Takahashi T; Urban RC
Exp Eye Res; 1996 Aug; 63(2):179-86. PubMed ID: 8983975
[TBL] [Abstract][Full Text] [Related]
10. Effect of synthesized constituents in the L-tryptophan product on the differentiation of eosinophils and the induction of IL-6: a possible cause of eosinophilia-myalgia syndrome.
Yamaguchi Y; Tsunoda J; Suda T; Miura Y; Shioiri-Nakano K; Kasahara T
Biochem Biophys Res Commun; 1991 Aug; 178(3):1008-13. PubMed ID: 1872826
[TBL] [Abstract][Full Text] [Related]
11. Identification of four metabolites of 3-(phenylamino)alanine, a constituent in L-tryptophan products implicated in eosinophilia-myalgia syndrome, in rats.
Adachi J; Mio T; Ueno Y; Naito T; Nishimura A; Fujiwara S; Sumino K; Tatsuno Y
Arch Toxicol; 1994; 68(8):500-5. PubMed ID: 7802590
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of tissue distribution and excretion among three substances implicated in eosinophilia-myalgia syndrome.
Adachi J; Ueno Y; Tatsuno Y; Gomez M; Smith CC; Sternberg EM
Adv Exp Med Biol; 1996; 398():365-70. PubMed ID: 8906290
[No Abstract] [Full Text] [Related]
13. Manipulation of the Precursor Supply in Yeast Significantly Enhances the Accumulation of Prenylated β-Carbolines.
Backhaus K; Ludwig-Radtke L; Xie X; Li SM
ACS Synth Biol; 2017 Jun; 6(6):1056-1064. PubMed ID: 28221769
[TBL] [Abstract][Full Text] [Related]
14. [A case of the eosinophilia-myalgia syndrome].
Ishikawa A; Akahosi T; Okada J; Kondo H; Kasiwazaki S
Ryumachi; 1992 Aug; 32(4):327-30; discussion 330-2. PubMed ID: 1411794
[TBL] [Abstract][Full Text] [Related]
15. On-line HPLC-tandem mass spectrometry analysis of contaminants of L-tryptophan associated with the onset of the eosinophilia-myalgia syndrome.
Williamson BL; Benson LM; Tomlinson AJ; Mayeno AN; Gleich GJ; Naylor S
Toxicol Lett; 1997 Jul; 92(2):139-48. PubMed ID: 9295237
[TBL] [Abstract][Full Text] [Related]
16. Tryptophan contaminants associated with eosinophilia-myalgia syndrome. The Eosinophilia-Myalgia Studies of Oregon, New York and New Mexico.
Philen RM; Hill RH; Flanders WD; Caudill SP; Needham L; Sewell L; Sampson EJ; Falk H; Kilbourne EM
Am J Epidemiol; 1993 Aug; 138(3):154-9. PubMed ID: 8356958
[TBL] [Abstract][Full Text] [Related]
17. A decomposition product of a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome affects spinal cord neuronal cell death and survival through stereospecific, maturation and partly interleukin-1-dependent mechanisms.
Brenneman DE; Page SW; Schultzberg M; Thomas FS; Zelazowski P; Burnet P; Avidor R; Sternberg EM
J Pharmacol Exp Ther; 1993 Aug; 266(2):1029-35. PubMed ID: 8355179
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of L-tryptophan impurities in meat products.
Lee DH; Kim YH; Baek M; Heo IK; Shin Y
Amino Acids; 2023 Feb; 55(2):173-182. PubMed ID: 36588144
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of potential association between L-tryptophan ingestion and eosinophilia-myalgia syndrome.
Daniels SR; Hudson JI; Horwitz RI
J Clin Epidemiol; 1995 Dec; 48(12):1413-27; discussion 1429-40. PubMed ID: 8543957
[TBL] [Abstract][Full Text] [Related]
20. Eosinophilia-myalgia syndrome associated with L-tryptophan. A case report with pulmonary manifestations and review of the literature.
André M; Canon JL; Levecque P; Dermine P; Mortier C; Leveau F
Acta Clin Belg; 1991; 46(3):178-82. PubMed ID: 1656679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
